The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Management, outcomes and predictors of recurrence in chromophobe renal cell carcinoma: Results from the Canadian Kidney Cancer information system (CKCis).
 
Erica Arenovich
No Relationships to Disclose
 
Rodney H. Breau
Honoraria - Astellas Pharma; Eisai; Knight Therapeutics; Merck; Tersera; Tersera; Tolmar
Research Funding - Tolmar
 
Ranjeeta Mallick
No Relationships to Disclose
 
Ricardo A. Rendon
Stock and Other Ownership Interests - Myovant Sciences
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Janssen
 
Andrew Feifer
No Relationships to Disclose
 
Frederic Pouliot
Stock and Other Ownership Interests - Allogene Therapeutics
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen; Novartis; Tersera; Tolmar
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; Tersera; Tolmar
Speakers' Bureau - Astellas Pharma; Bayer; Janssen
Research Funding - Astellas Pharma (Inst); Janssen (Inst); Merck (Inst); Tersera (Inst)
Patents, Royalties, Other Intellectual Property - Transcriptional system and uses therof for single cell detection
 
Simon Tanguay
Honoraria - Merck; Tersera
Consulting or Advisory Role - Merck; Tersera
 
Luke Lavallee
Consulting or Advisory Role - Astellas Pharma; Bayer; Ferring; Knight Pharmaceuticals; Knight Pharmaceuticals; Tersera; Tolmar
Research Funding - Tolmar (Inst)
 
Jean-Baptiste Lattouf
No Relationships to Disclose
 
Jasmir G. Nayak
Honoraria - Astellas Pharma; Tersera
Research Funding - Tersera (Inst); Zenflow (Inst)
 
Bimal Bhindi
Honoraria - Bayer; Merck
Consulting or Advisory Role - Bayer; Ferring; Janssen; Verity Pharmaceuticals
 
Rahul K. Bansal
Honoraria - Knight Therapeutics; McKesson Canada Corporation; Merck Canada Inc.
Consulting or Advisory Role - Knight Therapeutics; McKesson Canada Corporation
 
Antonio Finelli
Stock and Other Ownership Interests - Abbvie; Medtronic
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Merck; Tersera
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Tersera
 
Miles Mannas
Honoraria - Abbvie; Bayer; Janssen; Tersera
Consulting or Advisory Role - Bayer; Photocure
Travel, Accommodations, Expenses - Photocure
 
Patrick O. Richard
Honoraria - Astellas Pharma; Bayer; Janssen Oncology; Knight Pharmaceuticals; Tolmar
Consulting or Advisory Role - Astellas Pharma; Bayer; Novartis
Travel, Accommodations, Expenses - Bayer
 
Aly-Khan A. Lalani
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Merck; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Merck; Pfizer; Roche/Genentech
Research Funding - BioCanRx (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Ipsen (Inst); Novartis (Inst); Roche (Inst)
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
 
Georg A. Bjarnason
Honoraria - Bristol-Myers Squibb; Eisai; Ipsen; Merck; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Ipsen; Pfizer
Research Funding - Merck (Inst); Pfizer (Inst)
 
Naveen S. Basappa
Stock and Other Ownership Interests - illumiSonics
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Eisai; Ipsen; Janssen; Merck; Pfizer; Seagen; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EMD Serono; Ipsen; Janssen; Merck; Pfizer; Roche Canada; Seagen
Research Funding - Ipsen
Travel, Accommodations, Expenses - Eisai; Ipsen; Johnson & Johnson/Janssen; Pfizer
 
Lori Wood
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst); Roche Canada (Inst)
Travel, Accommodations, Expenses - Pfizer/EMD Serono